All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
How do we prepare for the next pandemic?
Edited by Tom Cohen |
26 October 2023
Vaccines
Industry Spotlight
How were the COVID-19 vaccines developed so fast? And why were some countries left behind?
Edited by Tom Cohen |
11 October 2023
Vaccines
Industry Spotlight
Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.
Edited by Ben Norris |
02 October 2023
Vaccines
Industry Spotlight
We take a look at what personalised cancer vaccines are, how they are developed, and how they are changing the field of immunotherapy.
Edited by Cara Digby-Patel |
15 September 2023
Vaccines
Industry Spotlight
We take a look at how the commercialisation of COVID-19 vaccines in the US will impact the price of the vital therapeutic.
Edited by Cara Digby-Patel |
19 July 2023
Vaccines
Industry Spotlight
April 25th marks World Malaria Day, an opportunity to raise awareness about the disease’s impact and efforts to control and prevent it.
Edited by Cara Digby-Patel |
25 April 2023
Vaccines
Commentary
Nexelis discussed the preclinical stage of vaccine development at Vaccines EU 2022, highlighting that the choices made during this stage will impact the rest of the development process.
03 April 2023
Vaccines
Whitepaper
30 March 2023
Vaccines
Industry Spotlight
New COVID variants are still a significant risk; but could an AI-generated universal COVID vaccine be the key to overcoming this?
Edited by Cara Digby-Patel |
16 March 2023
Vaccines

Search by Keyword

Filter by Subject Area

Biologics Series – Subjects

Filter by Content Type

Resource Formats (incl. Industry Spotlight)